Latest filing published 18 Jul 2019 for Inspire Medical Systems, Inc., €1.4M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Joyce Erony: trading record in brief
Filings by Joyce Erony span 2 companies, the busiest being Inspire Medical Systems, Inc. and Teligent, Inc. In total, 60 filings cover trades dated from 2 April 2009 to 18 July 2019.
In open-market terms, that means 3 purchases worth €1.7M on one side and 53 sales worth €95.2M on the other. Netting one side against the other leaves €93.6M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 share grants. Since January 2019: no purchases and 52 sales on the market.
In size, the median ticket on the buying side is €12k.
The latest filing, published on 18 July 2019, reports an open-market sale of €1.4M in Inspire Medical Systems, Inc. The last insider purchase was made public on 9 May 2018, 3,105 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Joyce Erony
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,738 shares@ US$68.271.8% of flowCommon StockSEC:0001213900-19-013152:0
- 53,964 shares@ US$68.284.3% of flowCommon StockSEC:0001213900-19-013152:1
- 39,750 shares@ US$67.973.1% of flowCommon StockSEC:0001213900-19-013152:2
- 41,075 shares@ US$66.633.2% of flowCommon StockSEC:0001213900-19-012782:1
- 31,519 shares@ US$66.792.4% of flowCommon StockSEC:0001213900-19-012782:0
- 52,866 shares@ US$68.604.2% of flowCommon StockSEC:0001213900-19-012782:2
- 98,355 shares@ US$67.607.7% of flowCommon StockSEC:0001213900-19-012464:0
- 38,122 shares@ US$65.772.9% of flowCommon StockSEC:0001213900-19-012464:1
- 54,715 shares@ US$66.704.2% of flowCommon StockSEC:0001213900-19-012464:2
- 32,073 shares@ US$55.432.1% of flowCommon StockSEC:0001213900-19-010008:0
- 34,495 shares@ US$56.052.3% of flowCommon StockSEC:0001213900-19-010008:1
- 23,004 shares@ US$54.171.4% of flowCommon StockSEC:0001213900-19-009744:0
- 600 shares@ US$54.120.0% of flowCommon StockSEC:0001213900-19-009744:1
- 20,449 shares@ US$54.391.3% of flowCommon StockSEC:0001213900-19-009744:2
- 12,854 shares@ US$54.820.8% of flowCommon StockSEC:0001213900-19-009526:0
- 26,388 shares@ US$54.381.7% of flowCommon StockSEC:0001213900-19-009526:1
- 137 shares@ US$54.000.0% of flowCommon StockSEC:0001213900-19-009526:2
- 37,946 shares@ US$53.922.3% of flowCommon StockSEC:0001213900-19-001832:0
- 20,035 shares@ US$53.541.2% of flowCommon StockSEC:0001213900-19-001655:0
- 15,311 shares@ US$52.940.9% of flowCommon StockSEC:0001213900-19-001655:1
- 16,708 shares@ US$52.631.0% of flowCommon StockSEC:0001213900-19-001655:2
- 34,752 shares@ US$53.652.1% of flowCommon StockSEC:0001213900-19-001457:0
- 19,120 shares@ US$52.491.1% of flowCommon StockSEC:0001213900-19-001457:1
- 13,149 shares@ US$52.560.8% of flowCommon StockSEC:0001213900-19-001457:2
- 12,773 shares@ US$52.400.8% of flowCommon StockSEC:0001213900-19-001279:0
25 of 58 declarations
